Ac<sub>2</sub>PIM-responsive miR-150 and miR-143 target receptor-interacting protein Kinase 2 and transforming growth factor beta-activated Kinase 1 to suppress NOD2-induced immunomodulators by Prakhar, Praveen et al.
Ac2PIM-responsive miR-150 andmiR-143 Target Receptor-
interacting Protein Kinase 2 and Transforming Growth Factor
Beta-activated Kinase 1 to Suppress NOD2-induced
Immunomodulators*
Received for publication,May 1, 2015, and in revised form, September 15, 2015 Published, JBC Papers in Press, September 21, 2015, DOI 10.1074/jbc.M115.662817
Praveen Prakhar‡1, Sahana Holla‡1, Devram Sampat Ghorpade‡1, Martine Gilleron§, Germain Puzo§, Vibha Udupa‡,
and Kithiganahalli Narayanaswamy Balaji‡2
From the ‡Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, Karnataka, India and
§Institut de Pharmacologie et de Biologie Structurale (IPBS), CNRS and Université de Toulouse, 31077 Toulouse, France
Background: Ac2PIM signals via TLR2 to direct both pro- and anti-inflammatory responses.
Results:Ac2PIM inducesmiR-150/143 via SRC-FAK-PYK2-CREB-P300 signaling to target RIP2 and TAK1 and subduesMDP-
stimulated PI3K-PKC-MAPK--catenin axis.
Conclusion: Ac2PIM-mediated TLR2 signaling suppresses the NOD2-induced immunomodulators viz. COX-2, SOCS-3, and
MMP-9.
Significance: TLR2-NOD2 crosstalk accentuated the utilities of Ac2PIM and MDP as vaccine adjuvant.
Specific and coordinated regulation of innate immune recep-
tor-driven signalingnetworks oftendetermines thenet outcome
of the immune responses. Here, we investigated the cross-regu-
lation of toll-like receptor (TLR)2 and nucleotide-binding olig-
omerization domain (NOD)2 pathways mediated by Ac2PIM, a
tetra-acylated form of mycobacterial cell wall component and
muramyl dipeptide (MDP), a peptidoglycan derivative respec-
tively. While Ac2PIM treatment of macrophages compromised
their ability to induce NOD2-dependent immunomodulators
like cyclooxygenase (COX)-2, suppressor of cytokine signaling
(SOCS)-3, andmatrixmetalloproteinase (MMP)-9, no change in
the NOD2-responsive NO, TNF-, VEGF-A, and IL-12 levels
was observed. Further, genome-wide microRNA expression
profiling identified Ac2PIM-responsive miR-150 and miR-143
to target NOD2 signaling adaptors, RIP2 and TAK1, respec-
tively. Interestingly, Ac2PIM was found to activate the SRC-
FAK-PYK2-CREB cascade via TLR2 to recruit CBP/P300 at the
promoters of miR-150 and miR-143 and epigenetically induce
their expression. Loss-of-function studies utilizing specific
miRNA inhibitors establish that Ac2PIM, via themiRNAs, abro-
gate NOD2-induced PI3K-PKC-MAPK pathway to suppress
-catenin-mediated expression of COX-2, SOCS-3, and
MMP-9. Our investigation has thus underscored the negative
regulatory role of Ac2PIM-TLR2 signaling on NOD2 pathway
which could broaden our understanding on vaccine potential or
adjuvant utilities of Ac2PIM and/or MDP.
Pattern recognition receptor (PRR)3 signaling is known to
orchestrate the innate immune responses in an antigen-pre-
senting cell like macrophage (1). Since themicrobial pathogens
usually harbor several pathogen-associated molecular patterns
(PAMPs), it is likely that multiple PRRs are activated during
infection of macrophages. Hence, signaling cascades down-
stream of the PRRs and their possible crosstalks essentially and
effectively regulate the cell-fate and immune responses (2, 3).
Among the PRRs, reports suggest extensive crosstalks of toll-
like receptors (TLRs) with other PRRs (2, 4, 5). Despite several
known nodes of interaction of TLRs with other PRRs, presence
of multiple ligands/PAMPs for some of the TLRs like TLR2
presents an interesting ligand-specific response that could dif-
ferentially fine-tune immune responses (6–8).
Phosphatidylmyo-inositol mannosides (PIMs) are the myco-
bacterial cell wall glycolipids recognized by TLR2. PIM2 and
PIM6 constitute the abundant classes of biosynthetic interme-
diates of lipomannan in mycobacteria and tetra-acylated PIMs
likeAc2PIM (previously called asAc4PIM2) are abundant forms
of PIMs (9, 10). During infection, PIMs traffic out of themacro-
phages andmediate signaling in the bystander uninfected cells,
thus act as an important modulator of immune responses dur-
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ing mycobacterial infection (10, 11). Functional consequences
of PIM-induced TLR2 signaling span both pro- and anti-in-
flammatory capacities (10, 12–15). Importantly, stimulation of
PIM-TLR2 pathway down-regulates TLR4-induced pro-in-
flammatory signals (13). However, mechanistic insights of such
PIM-mediated crosstalk of TLR2 with other PRRs need exten-
sive investigations. Interactions of TLR2 and nucleotide-bind-
ing oligomerization domain (NOD)2 signaling are reported in
several contexts. Surprisingly, both synergistic and antagonistic
crosstalks of the two PRRs are known (7, 8, 16).
NOD2 senses the bacterial peptidoglycan, muramyl dipep-
tide (MDP) (17, 18). On recognition of the cognate ligand,
NOD2 oligomerizes and activates the specific adaptor, recep-
tor-interacting protein 2 (RIP2). RIP2 then recruits and acti-
vates the transforming growth factor beta-activated kinase 1
(TAK1) complex to mediate the downstream signaling includ-
ing MAPK and nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-B) which in turn orchestrate NOD2-
induced immune responses (18, 19). NOD2 activation trans-
lates to the expression of several immunomodulators like
cyclooxygenase (COX)-2 (20), suppressor of cytokine signaling
(SOCS)-3 (21), matrix metalloproteinase (MMP)-9 (22), induc-
ible nitric-oxide synthase catalyzed NO (23), cytokines like
TNF- (10, 24), VEGF-A (25), and IL-12 (24, 26).WhileNOand
cytokines like TNF-, IL-12 mediate the NOD2-responsive
pro-inflammatory responses, COX-2, SOCS-3, MMP-9, and
VEGF-A constitutes the anti-inflammatory arm of the NOD2
responses. COX-2 catalyzes the rate-limiting step of conversion
of arachidonic acid to prostaglandin E2. Prostaglandin E2
directs several anti-inflammatory responses in macrophages
(27). SOCS-3 functions as a negative regulator of several cyto-
kines or a negative feedback for various signaling pathways
including the TLRs (28). Zn2- andCa2-dependentMMP-9 is
a class of endopeptidase that mediate both pro- and anti-in-
flammatory functions (29).
In the current study, we attempted to unravel the crosstalk, if
any, between Ac2PIM-mediated TLR2 signaling and MDP-in-
duced NOD2 pathway. Interestingly, we found that macro-
phages that were stimulated with Ac2PIM displayed marked
reduction in its ability to express NOD2-responsive immuno-
modulators like COX-2, SOCS-3, and MMP-9 but not NO,
TNF-, VEGF-A, or IL-12. This underscores the differential
regulatory abilities of Ac2PIM-induced TLR2 pathway on
NOD2 signaling. Ac2PIM indeed suppressed NOD2 responses
by downregulating the expression of RIP2 and TAK1, adaptors
of NOD2 signaling. Importantly, we identified Ac2PIM-
induced post-transcriptional mechanism presented by
microRNAs, miR-150 and miR-143, that targeted RIP2 and
TAK1, respectively. Deciphering themolecularmechanism, we
found that Ac2PIM signals via the TLR2-SRC-focal adhesion
kinase (FAK)-protein tyrosine kinase 2 (PYK2)-cAMP response
element-binding protein (CREB) pathway to mediate the
recruitment of a coactivator complex with intrinsic histone
acetyltransferase (HAT) functions, CREB-binding protein
(CBP)/P300 to the promoters of miR-150 and miR-143. Fur-
ther, NOD2-induced PI3K-PKC-MAPK--catenin signaling
axis, that was found to be crucial for the expression of the
immunomodulators, was significantly inhibited in the presence
of Ac2PIM. Together, this study has generated avenues to eval-
uate the vaccine potential and adjuvant utilities of Ac2PIM
and/or MDP.
Experimental Procedures
Cells and Mice—Brewer thioglycollate (8%)-elicited primary
macrophages were obtained from peritoneal exudates of wild-
type (C3H/HeJ or C57BL/6J) or tlr2-KO mice. Murine RAW
264.7macrophages cell line was obtained fromNational Center
for Cell Sciences, Pune, India. Macrophages were cultured in
DMEM (Gibco, Life Technologies) supplemented with 10%
heat-inactivated FBS (Gibco, Life Technologies) and main-
tained at 37 °C in 5% CO2 incubator. All strains of mice were
purchased from The Jackson Laboratory and maintained in
the Central Animal Facility (CAF), Indian Institute of Science
(IISc). All studies involving mice were performed after the
approval from the Institutional Ethics Committee for animal
experimentation as well as from Institutional Biosafety
Committee.
Reagents and Antibodies—General laboratory chemicals
were obtained from Sigma-Aldrich,MerckMillipore, HiMedia,
or Promega. Tissue culture plasticware was purchased from
Corning Inc. or Tarsons Products Pvt Ltd.MDPwas purchased
from Sigma-Aldrich. Ac2PIM was procured from Dr. Martine
Gilleron and Dr. Germain Puzo (IPBS, France). Anti-MMP-9
and HRP-conjugated anti--ACTIN antibodies were pur-
chased from Sigma-Aldrich and HRP-conjugated anti-rabbit
IgG antibody was purchased from Jackson ImmunoResearch.
Anti-COX-2was fromCalbiochem.Anti-P300was fromMerck
Millipore. Anti-Ser176 phospho-RIP2, anti-RIP2, anti-Ser412
phospho-TAK1, anti-TAK1, anti-SOCS-3, anti-Tyr458/199
phospho-p85, anti-p85, anti-Thr70 phospho-4EBP1, anti-
4EBP1, anti-Thr505 phospho-PKC, anti-Thr202/Tyr204
phospho-ERK1/2, anti-ERK1/2, anti-Thr180/Tyr182 phospho-
p38, anti-p38, anti-Tyr701 phospho-STAT1, anti-Tyr705
phospho-STAT3, anti-Ser33/37/Thr41 phospho--catenin,
anti-Ser9 phospho-GSK-3, anti-Tyr397 phospho-FAK, anti-
Tyr402 phospho-PYK2, anti-Tyr416 phospho-SRC, anti-
Ser133 phospho-CREB, and anti-H3K18ac antibodies were
obtained fromCell SignalingTechnology. TNF-, VEGF-A and
IL-12 ELISA kits were purchased from PeproTech.
Treatment with Pharmacological Reagents—Cells were
treatedwith the given pharmacological inhibitors (all fromCal-
biochem) 1 h prior to the experimental treatments at following
concentrations: PP2 (10 M), LY294002 (50 M), Rapamycin
(100 nM), Rottlerin (10M), U0126 (10M), SB203580 (10M),
SP600125 (50 M), -catenin inhibitor (15 M), LiCl (5 mM),
AG490 (10 M), HAT inhibitor (5 M), and FAK inhibitor (10
M). DMSO at 0.1% concentration was used as the vehicle con-
trol. In all experiments involving pharmacological reagents, a
tested concentration was used after careful titration experi-
ments assessing the viability of the macrophages using the
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) assay.
Ripk2 andMap3k7 3-UTRWT andMutation Generation—
The 3-UTRs of Ripk2 and Map3k7 were PCR amplified and
cloned into pmirGLO vector using the restriction enzymes SacI
and XbaI. Primer pairs used: WT Ripk2 3UTR forward 5-
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cgagctcgcaccgccttcaaatttccc-3, reverse 5-gctctagagcaacgtcat-
gggaagagact-3; WTMap3k7 3-UTR forward 5-cgagctcagca-
gatgatggcacctgt-3, reverse 5-gctctagaagtcagtaaacttgctctcct-
3. The miR-150 and miR-143 binding sites were mutated in
Ripk2 andMap3k7 3-UTR, respectively by nucleotide replac-
ements through site-directed mutagenesis using the mega-
primer inverse PCR method. The forward primer comprised
the desiredmutation and respective reverse primer was used to
generate megaprimers. Primer pairs used: Ripk2 megaprimer
forward 5-ccttctggtttaggaagtca-3, reverse 5-caacgtcatgggaa-
gagact-3;Map3k7 megaprimer forward 5-aaagtgctcgcttcaaa-
aatct-3, reverse 5-ctgccaccactcaccttta-3. The megaprimer
was further used to amplify theWT Ripk2 andMap3k7 3UTR
plasmid and generate the miR-150 Ripk2 and miR-143
Map3k7 3UTR plasmids, respectively.
Transfection Studies—Murine RAW 264.7 macrophages
were transfected with WT Ripk2 3-UTR, WT Map3k7
3-UTR, miR-150 Ripk2 3UTR, miR-143Map3k7 3-UTR,
-galactosidase, 100 nMmiRNA inhibitors (miR-150, miR-143,
or NC inhibitor from Ambion, Life Technologies) or miRNA
mimics (miR-26a, miR-150, miR-143, or NC mimics from
Ambion, Life Technologies) using low m. w. polyehtylenimine
(Sigma-Aldrich) as indicated. In all cases, 36 h post-transfec-
tion, the cells were treated as indicated and processed for
analysis.
Luciferase Assay—Cells were lysed in Reporter lysis buffer
(Promega) and assayed for luciferase activity using Luciferase
Assay Reagent (Promega) as per the manufacturer’s instruc-
tions. The results were normalized for transfection efficiencies
measured by -galactosidase activity. O-nitrophenol -D-ga-
lactopyranoside (HiMedia) was utilized for the -galactosidase
assay.
RNA Isolation and Real-Time qRT-PCR—Total RNA from
macrophages was isolated using TRI reagent (Sigma-Aldrich).
First strand cDNA synthesis was done with 1 g of total RNA
using First Strand cDNA synthesis kit (Applied Biological
Materials Inc.). Expression of target gene was assessed by Real-
Time quantitative Reverse Transcription-PCR (qRT-PCR)
using SYBRGreen PCRmix (KAPA Biosystems). All the exper-
iments were repeated at least three times independently to
ensure the reproducibility of the results. Gapdh was used as
internal control. The primers used for Real-Time qRT-PCR
amplification were as follows: Gapdh forward 5-gagccaaacgg-
gtcatcatct-3, reverse 5-gaggggccatccacagtctt-3; Ripk2
forward 5-gccattgagattccgcatcct-3, reverse 5-aacttcgtgattga-
gagagtgac-3 and Map3k7 forward 5-cggatgagccgttacagtatc,
reverse 5-actccaagcgtttaatagtgtcg-3. All the primers were
purchased from Eurofins Genomics.
miRNA Expression Profiling—Total RNA was isolated from
untreated, MDP-treated, and Ac2PIM and MDP co-treated
macrophages (n 2). Sample and reference RNAswere labeled
with Hy3 and Hy5, respectively using miRCURY LNATM array
power labeling kit (Exiqon). Sample and reference RNAhybrid-
ization was carried out in Tecan HS4800 hybridization station
(Tecan). The miRCURY LNATM array microarray slides were
scanned using a G2565BAmicroarray scanner system (Agilent)
and ImaGene (version 7.0) software (BioDiscovery) was used
for image analysis. The log median ratio of Hy3/Hy5 intensity
for replicative spots of each miRNA and the fold change in the
log median ratio for each sample was calculated. miRNAs that
exhibited increased fold expression in the Ac2PIM-MDP co-
treated samples when compared with MDP alone were clus-
tered and represented in the heat map. Data obtained were
analyzed by significance analysis ofmicroarrays (SAM) to iden-
tify differentially regulated miRNAs.
Quantification of miRNA Expression—Total RNA was iso-
lated from macrophages using TRI reagent. Real-Time qRT-
PCR for miR-26a, miR-150, and miR-143 was performed using
specific TaqMan miRNA assays (Ambion, Life Technologies)
as per manufacturer’s instructions. U6 snRNA was used as
internal control.
Immunoblotting Analysis—Cells were washed with 1 PBS
and lysed in RIPA buffer (50mMTris-HCl (pH 7.4), 1%Nonidet
P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA,
1 mM PMSF, 1 g/ml each of aprotinin, leupeptin, pepstatin, 1
mM Na3VO4, 1 mM NaF) on ice for 30 min. Whole cell lysates
were collected. After estimation of total protein by Bradford
reagent, equal amount of protein from each cell lysate was
resolved on 12% SDS-PAGE and transferred onto PVDF mem-
branes (Millipore) by semi-dry immunoblotting method (Bio-
Rad). 5%nonfat drymilk powder inTBST (20mMTris-HCl (pH
7.4), 137 mM NaCl, and 0.1% Tween 20) was used for blocking
nonspecific binding for 60 min. After washing with TBST, the
blots were incubated overnight at 4 °C with primary antibody
diluted in TBST with 5% BSA. After washing with TBST, blots
were incubatedwith anti-rabbit secondary antibody conjugated
to HRP for 2 h. The immunoblots were developed with
enhanced chemiluminescence detection system (PerkinElmer)
as permanufacturer’s instructions.-Actin was used as loading
control.
Enzyme Immunoassay (ELISA)—Cell-free culture superna-
tantswere used for performing ELISA forTNF-, VEGF-A, and
IL-12 (kits from PeproTech) as per the manufacturer’s instruc-
tions. Briefly, 96-well flat bottom plates (Nunc MaxiSorp,
Thermo Scientific) were coated with specific capture antibod-
ies overnight at 4 °C followed by three washes with 1 PBST
(1 PBSwith 0.05%Tween 20). After blocking with 1% BSA for
1 h at room temperature, wells were washed, and incubated
with cell-free culture supernatants for 2 h. After three washes
with 1 PBST, wells were incubated with respective detection
antibodies for 2 h at room temperature. Further, the wells were
washed and incubation with streptavidin-HRP antibody for 30
min at room temperature. The reactions were developed with
3,3,5,5-tetramethylbenzidine (Sigma-Aldrich) and the absor-
bance was measured at 450 nm using an ELISA reader (Molec-
ular Devices).
Estimation of NO—Cell-free culture supernatants were used
for estimating NO produced by macrophage. Greiss reagent
(Promega) was used to assay NO production according to the
manufacturer’s instructions. Briefly, nitrite standards and cell-
free supernatants were added to 96-well flat bottom plates
(Nunc MaxiSorp, Thermo Scientific). The samples were incu-
bated with equilibrated sulfanilamide solution for 10 min in
dark at room temperature. Further, N-1-napthylethylenedi-
amine dihydrochloride solution was added and incubated in
dark for 10 min before measuring the absorbance at 520 nm.
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Chromatin Immunoprecipitation (ChIP) Assay—ChIP assays
were carried out using a protocol providedbyUpstateBiotechnol-
ogy and Sigma-Adrich with certainmodifications. Briefly, macro-
phages were fixed with 1.42% formaldehyde for 15 min at room
temperature followed by quenching of formaldehyde with addi-
tion of 125mM glycine. Nuclei were lysed in 0.1% SDS lysis buffer
(50mMTris-HCl (pH 8.0), 200mMNaCl, 10mMHEPES (pH 6.5),
0.1% SDS, 10 mM EDTA, 0.5 mM EGTA, 1 mM PMSF, 1 g/ml of
each aprotinin, leupeptin, pepstatin, 1 mM Na3VO4, and 1 mM
NaF).Chromatinwas shearedusingBioruptorPlus (Diagenode) at
high power for 70 rounds of 30 s pulse ON/45 s OFF cycle at 4 °C.
Chromatin extracts containing DNA fragments with an average
size of 200–500 bp were immunoprecipitated using P300- or
pCREB-orH3K18ac-specific antibodiesor rabbitpreimmunesera
complexed with protein A-agarose beads (Merck Millipore).
Immunoprecipitated complexes were sequentially washed (Wash
BufferA: 50mMTris-HCl (pH8.0), 500mMNaCl, 1mMEDTA,1%
TritonX-100,0.1%Sodiumdeoxycholate,0.1%SDS,andprotease/
phosphatase inhibitors;Wash Buffer B: 50mMTris-HCl (pH 8.0),
1 mM EDTA, 250 mM LiCl, 0.5% Nonidet P-40, 0.5% sodium
deoxycholate, and protease/phosphatase inhibitors; TE: 10 mM
Tris-HCl (pH 8.0), 1 mM EDTA with protease inhibitors) at 4 °C
andeluted in elutionbuffer (1%SDS, 0.1MNaHCO3) at 65 °C.The
eluted sample was treated with RNase A and Proteinase K, DNA
was precipitated using phenol-chloroform-ethanol method. Puri-
fied DNAwas analyzed for CREB-binding sites on the promoters
ofmiR-150andmiR-143byReal-TimeqRT-PCR.Primersused: at
miR-150 promoter forward 5-gaactgaatcctttgacctctac-3, reverse
5-gaactgaatcctttgacctctac-3; at miR-143 promoter forward 5-
gacaaagaggcaggggacg-3, reverse 5-cagtaagtagctaggagtggtg-3.
All values in the test samples were normalized to amplification of
the specific gene in Input and IgG pull down and represented as
fold change in enrichment or modification.
Statistical Analysis—Levels of significance for comparison
between samples were determined by the Student’s t test distri-
bution and one-way ANOVA. The data in the graphs are
expressed as themean S.E. for values from three independent
experiments and p values  0.05 were defined as significant.
GraphPad Prism 5.0 software (GraphPad Software) was used
for all the statistical analysis.
Results
Ac2PIM Inflects NOD2-induced Immunomodulators—Con-
founding to several studies where PIM2 was found to be pro-
inflammatory in its function (10, 12), several members of PIM
family that are TLR2 agonists are majorly anti-inflammatory in
nature and can suppress pro-inflammatory responsesmediated
by other PRRs (13–15). We sought to analyze the cross-regula-
tion, if any, between PIM-induced TLR2 signaling and another
PRR signaling like NOD2 pathway. While Ac2PIM, one of the
abundant PIMs of mycobacteria (9), was utilized as TLR2 ago-
nist, MDP was utilized as the NOD2 agonist. Canonical NOD2
activation leads to the recruitment and active phosphorylation
of the cytosolic adaptor proteins, RIP2 andTAK1. Interestingly,
prior activation of TLR2 signaling by Ac2PIM significantly sup-
pressed MDP-induced active phosphorylation of RIP2 and
TAK1 (Fig. 1A). To establish if such inhibition had effects on
the downstream responses, we chose to analyze the known
FIGURE1.Ac2PIMdifferentially regulatesNOD2-induced immune response.A, peritonealmacrophageswere treatedwithAc2PIM followedbyMDP for the
indicated timepoints. Lysateswere analyzed for pRIP2 andpTAK1by immunoblotting.B-D, immunoblot analysis of COX-2, SOCS-3, andMMP-9wasperformed
on lysates obtained frommacrophages after the following treatments: treatmentwith pharmacological inhibitor PP2 prior to 12 hMDP addition (B), treatment
with indicated concentrations of Ac2PIM followed by 12 h treatment of MDP (C), and pretreatment of macrophages from C57BL/6J WT and tlr2-KOmice with
Ac2PIM followed by MDP for 12 h (D). E–H, macrophages were pretreated with indicated concentration of Ac2PIM followed by MDP for 12 h. Cell-free
supernatants were analyzed for NO by Greiss reagent (E), TNF- (F), VEGF-A (G), and IL-12 (H) by ELISA. All data represent the mean  S.E. from three
independent experiments, ***, p 0.001 (one-way ANOVA) and all blots are representative of three independent experiments. The cells were treated with 2
g/ml Ac2PIM unless mentioned otherwise for 2 h followed by 200 ng/ml MDP.Med, medium;WT, wild-type; KO, knock-out; DMSO, dimethyl sulfoxide.
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NOD2-responsive immunomodulatory genes such as COX-2,
SOCS-3, MMP-9. In accordance with the existing literature,
MDP-NOD2 failed to induce the expression of COX-2,
SOCS-3, and MMP-9 in presence of the RIP2 inhibitor, PP2
(Fig. 1B). Surprisingly, though MDP or Ac2PIM treatment
alone induced the expression of COX-2, SOCS-3, and MMP-9
in macrophages, prior engagement of TLR2 with Ac2PIM sig-
nificantly down-regulated the ability of NOD2 to induce these
genes (Fig. 1C). Ability of Ac2PIM to signal through TLR2 to
mediate such functions was confirmed inmacrophages derived
from tlr2-KO mice wherein pretreatment of Ac2PIM failed to
suppress the expression of the candidate genes (Fig. 1D). How-
ever, other NOD2-responsive immunomodulators like NO,
TNF-, VEGF-A, and IL-12 remained unchanged during co-
treatment with Ac2PIM (Fig. 1, E–H). These results collectively
indicate a differential regulation of NOD2 responses by
Ac2PIM-induced TLR2 signaling.
Ac2PIM-responsivemiRNAsTarget RIP2 andTAK1 toDown-
regulate NOD2Responses—Further, we investigated themolec-
ular mechanism that govern the Ac2PIM-induced suppression
of NOD2 signaling. As Ac2PIM abrogated the active phosphor-
ylation of NOD2-induced RIP2 and TAK1 (Fig. 1A), transcript
and total protein of RIP2 and TAK1 were assessed. Interest-
ingly, while no significant difference inRipk2 andMap3k7 tran-
scripts were observed with individual or co-treatment of
Ac2PIM andMDP (Fig. 2A), marked reduction in the total RIP2
and TAK1 protein was observed when the cells were treated
with Ac2PIM prior to MDP (Fig. 2B). This indicated a possible
FIGURE 2.miR-150 andmiR-143 target RIP2 and TAK1 kinases. A and B, peritoneal macrophages were pretreatedwith Ac2PIM followed byMDP treatment
for 2h. Transcript (A) andprotein (B) levels of RIP2 andTAK1weredeterminedbyReal-TimeqRT-PCRand immunoblotting respectively.C,genome-widemiRNA
microarray profiling was done in macrophages treated as indicated. A heat map comparison of miRNAs that exhibited increased fold expression in the
Ac2PIM-MDP co-treated samples when comparedwithMDP alone (n 2).D, putativemiR-26a, miR-150 andmiR-143 binding sites in the CDS of Ripk2, 3-UTR
of Ripk2 and 3-UTR ofMap3k7, respectively. E and F, peritonealmacrophageswere treatedwith Ac2PIM alone for 4 h (E) or with Ac2PIM for 2 h prior to 2 hMDP
treatment (F). Real-Time qRT-PCR was performed on total RNA isolated using miRNA-specific primers. G, RAW 264.7 macrophages were transfected with
specific miRNA mimics as indicated to assess the total expression levels of RIP2 and TAK1 by immunoblotting. H and I, RAW 264.7 macrophages were
transfectedwithWTRipk23-UTRormiR-150Ripk23-UTR (H) orWTMap3k73-UTRormiR-143Map3k73UTR (I)withmiR-150mimics (H) ormiR-143mimics
(I) as indicated. Transfectedmacrophageswere further treatedwithMDPor Ac2PIMor both and luciferase assaywas performed. All data represent themean
S.E. from three independent experiments, *, p 0.05; **, p 0.005; ***, p 0.001; ns, non-significant (t test in E, one-way ANOVA in F, H, and I). All blots are
representative of three independent experiments. The cellswere treatedwith 2g/mlAc2PIM for 2 hunlessmentionedotherwise followedby200ng/mlMDP.
Med, medium; NC, negative control.
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involvement of post-transcriptional regulation, like those
mediated by miRNAs, of RIP2 and TAK1 by Ac2PIM-induced
TLR2 signaling. In this regard, we carried out a genome-wide
expression profiling of miRNAs in macrophages treated with
MDP alone or co-treated with Ac2PIM. Among the various dif-
ferentially regulated miRNAs, we identified and clustered the
miRNAs that exhibited increased expression in the Ac2PIM-
MDP co-treated samples when comparedwithMDP alone (Fig.
2C). Extensive bioinformatic analysis (TargetScan, miRWalk,
miRanda and RNAhybrid) identified Ripk2 as a potential target
of miR-26a and miR-150 and Map3k7 as a potential target of
miR-143 (Fig. 2D). The target sites located at the residues span-
ning from 867 to 873 of the coding sequence of Ripk2 (for miR-
26a), 12 to 18 of the 3-UTR of Ripk2 (for miR-150) and 380 to
387 of the 3-UTR ofMap3k7 (for miR-143) were identified as
critical for miRNA-CDS/3-UTR interactions.
Validating the microarray results, macrophages treated with
Ac2PIM alone (Fig. 2E) or co-treated with MDP (Fig. 2F) dis-
played increased expression of miR-26a, miR-150, and miR-
143. Importantly, MDP treatment alone did not alter the
expression of these miRNAs (Fig. 2F). To establish the effect of
these miRNAs on the identified targets, miRNA-specific mim-
ics were utilized.WhilemiR-26amimic failed to down-regulate
RIP2 expression, miR-150 and miR-143 were identified as the
Ac2PIM-responsive miRNAs that targeted RIP2 and TAK1
respectively (Fig. 2G). To further establish that Ripk2 and
Map3k7 are the bonafide targets of miR-150 and miR-143, we
utilized the classical 3-UTR luciferase assays. In line with the
previous results, Ac2PIM, or co-treatment of Ac2PIM with
MDP or transfection with miR-150 (in case of Ripk2) or miR-
143 (in case of Map3k7) mimics markedly reduced WT Ripk2
and Map3k7 3-UTR luciferase activity. However, the reduc-
tion was not significant when mutant constructs for miR-150
binding on Ripk2 3UTR and miR-143 binding site onMap3k7
3-UTR were utilized (Fig. 2, H and I). These results thus vali-
date that Ripk2 andMap3k7 are direct targets of miR-150 and
miR-143 respectively. Further, macrophages transfected with
miR-150- or miR-143-specific inhibitors failed to down-regu-
late RIP2 andTAK1 expression in presence ofAc2PIM (Fig. 3,A
and B). Corroborating these results, macrophages transfected
with miR-150- or miR-143-specific inhibitors also failed to
exhibit Ac2PIM-mediated suppression of MDP-NOD2 signal-
ing-induced expression of COX-2, SOCS-3, andMMP-9 (Fig.
3, C and D).
SRC-FAK-PYK2-CREB Signaling Mediates Ac2PIM-induced
Expression of miR-150 and miR-143 via CBP/p300 Re-
cruitment—Further, we explored the possible molecular mech-
anism of Ac2PIM-induced miR-150 and miR-143 expression.
Role for TLR2 in mediating the expression of these miRNAs
was validated in primary macrophages obtained from tlr2-KO
mice. Ac2PIM stimulation failed to induce both miR-150 and
miR-143 in tlr2-KOmacrophages (Fig. 4A). Of note, TLR2 acti-
vatesmultiple signaling cascades to regulate immune responses
inmacrophages including several tyrosine kinase receptor fam-
ily receptors like SRC, FAK, and PYK2 (30). Interesting reports
also indicate that FAK signaling couldmediate the activation of
a cellular transcription factor, CREB and its binding to theDNA
(31, 32). Hence, we explored the role of TLR2-dependent acti-
vation of the SRC-FAK-PYK2 complex and a possible down-
stream CREB-dependent CBP/P300 functions in the current
scenario. While macrophages obtained from WT mice exhib-
ited activation of SRC-FAK-PYK2 complex and CREB on
Ac2PIM stimulation as assessed by the respective activatory
phosphorylations, tlr2-KO macrophages failed to do so (Fig.
4B). Importantly, stimulation of macrophages with MDP alone
did not induce the pathway (Fig. 4B). We also confirmed the
Ac2PIM-induced FAK-dependent CREB activation by utilizing
FAK-specific pharmacological inhibitor (Fig. 4C). Activation of
CREB leads to its binding to theCBP/P300 coactivator complex
that is recruited to the DNA to bring about transcriptional acti-
vation via its HAT functions (33). To establish the role for the
abovementioned pathway during the Ac2PIM-induced expres-
sion of miR-150 and miR-143, macrophages were treated with
FAK- or HAT-specific pharmacological inhibitors prior to
Ac2PIM treatment. Macrophages failed to induce the expres-
sion of both miR-150 and miR-143 on Ac2PIM stimulation in
presence of these inhibitors (Fig. 4D). The role for CREB-CBP/
P300 in expression of Ac2PIM-induced miR-150 and miR-143
was further validated by ChIP experiments. Corroborating the
previous results, Ac2PIM-stimulation of macrophages resulted
in significant recruitment of pCREB, P300, and corresponding
increased H3K18 acetylation at both miR-150 and miR-143
promoters (Fig. 4E). This suggests thatAc2PIMactivates TLR2-
SRC-FAK-PYK2 complex, which in turn effectuates CREB acti-
vation, recruitment of CREB-CBP/P300 at the promoters of
miR-150 and miR-143 and their expression. Analyzing the
functional significance of the identified pathway, we found that
primary macrophages pretreated with FAK or HAT inhibitors
failed to exhibit Ac2PIM-mediated suppression ofMDP-NOD2
signaling-induced expression of COX-2, SOCS-3, and
MMP-9 (Fig. 4F).
FIGURE 3.Ac2PIM-inducedmiR-150 andmiR-143 target RIP2 andTAK1 to
down-regulate MDP responses. A and B, RAW 264.7 cells were transfected
with miR-150- (A) or miR-143- (B) specific miRNA inhibitors followed by 4 h
treated with Ac2PIM. RIP2 (A) and TAK1 (B) expression were analyzed by
immunoblotting. C and D, miR-150- (C) or miR-143- (D) specific miRNA inhib-
itor-transfected RAW 264.7 macrophages were treated with Ac2PIM prior to
MDP treatment for 12h. Lysateswere assessed forCOX-2, SOCS-3, andMMP-9
by immunoblotting. All blots are representative of three independent exper-
iments. The cells were treated with 2g/ml Ac2PIM for 2 h unless mentioned
otherwise followed by 200 ng/ml MDP. Med, medium; NC, negative control;
Inhi., inhibitor.
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FIGURE4.Ac2PIMinducestheexpressionofmiR-150andmiR-143viaSRC-FAK-PYK2-CREB-CBP/P300axis.A,macrophages fromC57BL/6JWTand tlr2-KOmice
were treatedwithAc2PIMfor4handreal-timeqRT-PCRwasperformedontotalRNA isolatedusingmiRNA-specificprimers.B, peritonealmacrophages fromC57BL/6J
WT and tlr2-KOmicewere treatedwithAc2PIMorMDP for 1 h as indicated. Total cell lysateswere assessed for pFAK, pPYK2, pSRC, andpCREBby immunoblotting.C,
macrophages were treated with FAK-specific inhibitor for 1 h prior to 1 h Ac2PIM treatment and lysates were analyzed for pCREB by immunoblotting. D, primary
macrophages pretreatedwith either FAK inhibitor or HAT inhibitor for 1 hwere treatedwithAc2PIM for 4 h. Real-TimeqRT-PCRwas performedusingmiRNA-specific
primers. E, pCREB and P300 recruitment and H3K18ac modification at the promoters of miR-150 andmiR-143 was evaluated by ChIP in macrophages treated with
Ac2PIM for4h.F,peritonealmacrophageswere treatedwith indicated inhibitors for 1hprior to2hAc2PIMtreatment followedbya12hMDPtreatment. Lysateswere
assessedforCOX-2,SOCS-3,andMMP-9by immunoblotting.Alldatarepresent themeanS.E. fromthree independentexperiments, *,p0.05; **,p0.005;***,p
0.001 (one-way ANOVA in A and D, t test in E). All blots are representative of three independent experiments. All blots are representative of three independent
experiments.Thecellswere treatedwith2g/mlAc2PIMfor2hunlessmentionedotherwise followedby200ng/mlMDP.Med,medium;KO, knock-out; Inhi., inhibitor.
FIGURE 5. Ac2PIM regulates MDP-induced activation of PI3K-PKC-MAPK pathway. A, peritoneal macrophages were treated with specific pharmacological
inhibitors of PI3K-PKC-MAPKpathway suchas LY294002 (PI3K inhibitor), Rapamycin (mTOR inhibitor), Rottlerin (PKC inhibitor), U0126 (ERK1/2 inhibitor), SB203580
(p38 inhibitor), andSP600125(JNK1/2 inhibitor)prior to12hMDPtreatment.Totalcell lysateswereanalyzedforCOX-2,SOCS-3,andMMP-9by immunoblotting.Band
C, activation of PI3K pathway (B) and PKC-MAPK pathway (C) was analyzed inmacrophages pretreatedwith Ac2PIM followed byMDP for the indicated time points.
D, activationofPI3K-PKC-MAPKpathwaywasassessedunder the followingconditions: Peritonealmacrophageswerepretreatedwith the indicated inhibitors for1h
followed by Ac2PIM andMDP treatment for 2 h (D, left panel), RAW264.7 cells transfectedwithmiR-150- (D,middle panel), ormiR-143- (D, right panel) specificmiRNA
inhibitors were treatedwith Ac2PIM followed by 2 h ofMDP treatment. All blots are representative of three independent experiments. The cells were treatedwith 2
g/ml Ac2PIM for 2 h followed by 200 ng/mlMDP.Med, medium;NC, negative control; Inhi., inhibitor;DMSO, dimethyl sulfoxide.
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Ac2PIM Down-regulates PI3K-PKC-MAPK Signaling to
Modulate NOD2 Responses—Having established that miR-150
and miR-143 target RIP2 and TAK1 to suppress NOD2
responses, we sought to identify the molecular mechanism
downstream to RIP2-TAK1 that mediates COX-2, SOCS-3,
and MMP-9 expression. Pharmacological inhibition of
PI3K-PKC-MAPK signaling significantly down-regulated
NOD2-induced COX-2, SOCS-3, and MMP-9 expression in
macrophages (Fig. 5A). In line with this result, we found that
macrophages treated with Ac2PIM failed to activate NOD2-
induced PI3K-PKC-MAPK signaling (Fig. 5, B and C).
Importantly, peritoneal macrophages pretreated with FAK
or HAT inhibitors or in cells transfected with miR-150- or
miR-143-specific inhibitors, Ac2PIM was not effective to
subdue NOD2-activated PI3K-PKC-MAPK signaling
(Fig. 5D).
-Catenin Activation by MDP Facilitates COX-2, SOCS-3,
andMMP-9 Expression—To further elucidate the downstream
regulators of NOD2 responses, we performed MatInspector
analysis of the promoters of mouse COX-2, SOCS-3, and
MMP-9. STATs and -catenin were among the common tran-
scription factors that could regulate COX-2, SOCS-3, and
MMP-9. Phosphorylation of STAT1 at Tyr-701 and STAT3 at
Tyr-705 renders them active whereas phosphorylation of
-catenin at Ser-33/37/Thr-41 and glycogen synthase
kinase-3 (GSK-3) at Ser-9 renders them inactive. Active
GSK-3 phosphorylates -catenin at Ser-33/37/Thr-41 to
turn it inactive. Here, while MDP-triggered NOD2 did not
signal STAT activation (Fig. 6A), NOD2-induced suppres-
sion of GSK-3 and hence activation of -catenin (Fig. 5B,
left panel) was subverted in the presence of Ac2PIM (Fig. 6B,
right panel). In support of our previous data, MDP-NOD2-
induced -catenin activation was found to be PI3K-MAPK
pathway dependent (Fig. 6C). Substantiating these observa-
tions, expression of NOD2-responsive immunomodulators
COX-2, SOCS-3, andMMP-9 were not altered by JAK-STAT
pathway inhibition but significantly down-regulated in the
presence of -catenin inhibitor and significantly up-regu-
lated in the presence of GSK-3 inhibitor (Fig. 6D). Impor-
tantly, macrophages pretreated with FAK or HAT inhibitors
(Fig. 6E) or macrophages transfected with miR-150- or miR-
143-specific inhibitors failed to exhibit Ac2PIM-mediated
suppression of -catenin activation on NOD2 stimulation
(Fig. 6F). Together, these results suggest that Ac2PIM-re-
sponsive miR-150 and miR-143 suppressed the NOD2-in-
duced -catenin activation and -catenin-dependent gene
expression.
Discussion
Commonly, a concerted inter-regulatory network of PRR sig-
naling determines the immune responses mounted against the
pathogen/PAMPs (1, 34). In the current investigation, we ana-
FIGURE 6. Ac2PIM regulates NOD2--catenin-mediated COX-2, SOCS-3, and MMP-9 expression. A, peritoneal macrophages were pretreated with a
pharmacological inhibitor of JAK kinase (AG490) followed by treatment with MDP or IFN- (200 units/ml) to analyze phosphorylation status of STAT1 and
STAT3. B and C, inhibitory phosphorylation status of -catenin and GSK-3 during the following conditions: treatment of macrophages with MDP for the
indicated time points (B), pretreatment of macrophages with PI3K-MAPK pathway-specific pharmacological inhibitors followed byMDP treatment for 6 h (C).
D, peritoneal macrophages were treated with AG490, -catenin inhibitor or LiCl (GSK-3 inhibitor) prior to 12 h MDP treatment. Lysates were assessed for
COX-2, SOCS-3, and MMP-9 by immunoblotting. E and F, Phosphorylation status of -catenin and GSK-3was assessed by immunoblotting under following
conditions: Peritoneal macrophages were pretreated with the indicated inhibitors for 1 h followed by Ac2PIM and MDP treatment for 6 h (E), miR-150- (left
panel) or miR-143- (right panel) specific miRNA inhibitor-transfected RAW 264.7 macrophages were treated with Ac2PIM prior to MDP treatment for 6 h (F). All
blots are representative of three independent experiments. The cells were treated with 2 g/ml Ac2PIM for 2 h followed by 200 ng/ml MDP. Med, medium;
DMSO, dimethyl sulfoxide; NC, negative control; Inhi., inhibitor; LiCl, lithium chloride.
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lyzed the crosstalk of two important families of PRR, TLRs, and
NLRs. Specifically, a mycobacterial cell wall glycolipid Ac2PIM
and component of bacterial peptidoglycan MDP were utilized
as cognate ligands for TLR2 and NOD2 pathway. Interestingly,
Ac2PIM-stimulated TLR2 signaling was found to abrogate
NOD2-responsive immune modulators. This was in accord-
ance with the previous observations of antagonistic regulation
between TLR2-NOD2 signaling wherein NOD2 was found to
negatively regulate TLR2-induced Th1 responses (6, 7). The
agonist used in the study was peptidoglycan, a bacterial PAMP
common for both pathways. However, NOD2-TLR2 can also
synergistically induce inflammatory responses (16, 35). Fur-
ther, there exists a cooperative regulation of NOD2- andTLR2-
specific ligands for mediating immune cytokines (8, 36, 37).
NOD2-TLR2 synergy was also found in different cellular con-
texts (38, 39). Thus, the present study underscores the fact that
though multiple PAMPs recognize a single PRR, there exist
regulatory mechanisms to orchestrate the ligand-specific
immune responses.
Ac2PIM was potent to inhibit COX-2, SOCS-3, and MMP-9
expression but did not alter the levels of NO, TNF-, VEGF-A,
and IL-12 during co-treatment with MDP. This was surprising
as Ac2PIM alone, like MDP, could upregulate these immuno-
modulators. Supporting this observation, monoacyl form of
PIM2was previously reported to have induced the expression of
these immunomodulators (40, 41).
Of note, though classical NOD2 responses via RIP2 and
TAK1 are well established, various previous investigations have
suggested that MDP-induced NOD2 responses could be RIP2/
TAK1-independent (42, 43). However, in the current study, we
found role for the classical NOD2 responses. Deciphering the
mechanism of Ac2PIM-arbitrated inhibition of MDP-NOD2
responses, we found miRNA-mediated regulation of RIP2
and TAK1 expression. Extensive studies on TLR-responsive
miRNAs suggest a role for miRNAs in not only orchestrating
innate immune responses or a negative feed-back loop (44–48)
but also negatively regulate responses mediated by other PRRs
including NOD2 (49). Here, miR-150 and miR-143 were found
to be induced by Ac2PIM-stimulation of macrophages that tar-
geted the NOD2 adapters, RIP2 and TAK1, respectively.
Though several investigations have implicated miR-150 in reg-
ulating innate immune responses (45, 50–52), no reports on
miR-150 and regulation of RIP2 or NOD2 signaling exists.
Interestingly, supporting our data,miR-143has beenpreviously
reported to regulate immune responses in various cellular con-
texts (53–55) and target TAK1 in mesenchymal stem cells (56)
and adipocytes (57).
Though few reports have indicated the crosstalk betweenTLR2
signaling and SRC-FAK-PYK2 complex (30, 58, 59), no reports
exist on the molecular mechanism induced by Ac2PIM via TLR2.
We found Ac2PIM activated TLR2-SRC-FAK-PYK2 cascade to
induce expression of miR-150 and miR-143. FAK and PYK2
kinaseswere previously reported for their possible abilities to acti-
vateCREB responses (31, 32, 60).Other investigations have impli-
cated CREB activation to mediate TLR2-mediated immune func-
tions (47, 61). In linewith these, we found SRC-FAK-PYK2 signals
to activate CREB and induce CREB-CBP/P300 recruitment to
miR-150 andmiR-143 promoters and epigenetically regulate their
expression via the intrinsic HAT activity.
Further, we also established that NOD2-induced immuno-
modulators were mediated by the classical PI3K-PKC-MAPK
cascade in tandem with -catenin signaling. While MDP-trig-
gered NOD2 signals to activate PI3K-PKC-MAPK pathways in
macrophages and dendritic cells (8, 18, 20), PI3K-PKC-MAPK
pathway was also previously found to regulate the immuno-
modulators like COX-2, SOCS-3, and MMP-9 in macrophages
on TLR2 stimulation by mycobacteria (62–64). Of note,
NOD2-responsive -catenin signaling exacerbates several
pathologies including inflammatory disorders and arthritis (42,
65). -Catenin also regulates COX-2 and SOCS-3 expression
duringmycobacterial infection (66). Ac2PIM-inducedmiR-150
and miR-143 via the TLR2-SRC-FAK-PYK2-CREB-CBP/P300
axis targeted RIP2 and TAK1 to abrogate NOD2-reponsive
PI3K-PKC-MAPK--catenin signaling-mediated expression
of COX-2, SOCS-3, andMMP-9 (Fig. 7). The PRR agonists like
PIM2 (15, 67–69) andMDP (70, 71) are potent vaccine adjuvant
candidates. Thus, our study has accentuated the cross-regula-
tion of the respective PRR in a coactivation scenario, which can
contribute to better understanding of the adjuvant utilities of
Ac2PIM and MDP.
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Ac2PIM for the study. V. U. performed experiments. P. P., S. H., and
K. N. B. wrote the manuscript. K. N. B. designed experiments, ana-
lyzed data, and supervised the study.
FIGURE 7. Model. Ac2PIM-responsive, TLR2-SRC-FAK-PYK2-CREB-CBP/P300-
dependentmiRNAs,miR-150 andmiR-143, target RIP2 andTAK1, respectively
to suppress NOD2-induced PI3K-PKC-MAPK--catenin-mediated expres-
sion of immunomodulators like COX-2, SOCS-3, and MMP-9.
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